학술논문
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
Document Type
Article
Author
Source
In: Cancer . (Cancer, 15 February 2016, 122(4):588-597)
Subject
Language
English
ISSN
10970142
0008543X
0008543X